← Back to Search
Network Meta-analysis For Indirect Treatment Comparisons.
Published 2002 · Medicine, Mathematics
Download PDFAnalyze on Scholarcy
I present methods for assessing the relative effectiveness of two treatments when they have not been compared directly in a randomized trial but have each been compared to other treatments. These network meta-analysis techniques allow estimation of both heterogeneity in the effect of any given treatment and inconsistency ('incoherence') in the evidence from different pairs of treatments. A simple estimation procedure using linear mixed models is given and used in a meta-analysis of treatments for acute myocardial infarction.
This paper references
A Language and Program for Complex Bayesian Modelling
W. Gilks (1994)
Criteria for the validation of surrogate endpoints in randomized experiments.
M. Buyse (1998)
Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence: International Joint Efficacy Comparison of Thrombolytics
R. Wilcox (1995)
Meta-analysis for the evaluation of potential surrogate markers.
M. Daniels (1997)
Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction.
E. Ribeiro (1993)
An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure.
M. Garcia (1997)
Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.
R. Gibbons (1993)
A comparison of reteplase with alteplase for acute myocardial infarction
Global Use (1997)
MEDICAL SCIENCE: GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction
Gruppo Italiano Per LO Studio Della Sopravvivenza NELL'IN Miocardico (1990)
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
C. Bode (1996)
Fibrinolytics vs primary angioplasty in acute myocardial infarction (FAP): A randomized trial in a community hospital in Argentina
L. Grinfeld (1996)
Randomized, double blind comparison of reteplase double bolus administration with streptokinase in acute myocardial infarction (inject): Trial to investigate equivalence
P. Berger (1996)
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
M. Simoons (1993)
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
David Hunt (1992)
Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction.
F. Zijlstra (1997)
Meta-analysis in clinical trials.
R. Dersimonian (1986)
A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.
M. Simoons (1997)
Bayes Methods for Combining the Results of Cancer Studies in Humans and other Species
W. H. Dumouchel (1983)
This paper is referenced by
Systematic review and network meta-analysis with individual participant data on Cord Management at Preterm Birth (iCOMP): study protocol
A. Seidler (2019)
Erratum to: Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review
W. Zarin (2017)
Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons
B. Carlin (2013)
Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis
G. Désaméricq (2013)
A framework for identifying treatment‐covariate interactions in individual participant data network meta‐analysis
S. Freeman (2018)
Indirect Treatment Comparison
B. Miladinović (2014)
Hemodynamic management and surgical site infection: Network meta-analysis of randomized controlled trials.
Xueqiang Zhao (2020)
Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.
Pascale Dequen (2012)
A graphical tool for locating inconsistency in network meta-analyses
U. Krahn (2013)
Pitfalls of Systematic Reviews and Meta-Analyses in Imaging Research.
M. McInnes (2015)
Graphical Options for Examining Contributions to Q
M. H. Murad (2018)
The use of two-way linear mixed models in multitreatment meta-analysis.
H. Piepho (2012)
Network meta-analysis with competing risk outcomes.
A. Ades (2010)
Meta-Analysis of Therapeutic Trials
J. Cappelleri (2018)
Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta‐analysis
X. Zhou (2015)
D. B. Wilson (2016)
Tapentadol Prolonged Release for Chronic Pain: A Review of Clinical Trials and 5 Years of Routine Clinical Practice Data
R. Baron (2017)
A novel approach indirectly comparing benefit-risk balance across anti-thrombotic therapies in patients with atrial fibrillation.
A. Dogliotti (2015)
Balancing benefit and risk of medicines: a systematic review and classification of available methodologies
S. Mt-Isa (2014)
Combination of direct and indirect evidence in mixed treatment comparisons.
G. Lu (2004)
Network Meta-Analysis for Complex Social Interventions: Problems and Potential
E. Grant (2013)
The effect of aspirin and low-molecular-weight heparin on venous thromboembolism after hip replacement: a non-randomised comparison from information in the National Joint Registry.
S. Jameson (2011)
Evidence Synthesis for Decision Making 2
S. Dias (2013)
Meta-analysis as the core of evidence-based behavioral medicine: tools and pitfalls of a statistical approach
Y. Nestoriuc (2010)
Making better use of clinical trials: computational decision support methods for evidence-based drug benefit-risk assessment
Gerardus Hendrikus Margondus van Valkenhoef (2012)
Stroke prevention--insights from incoherence.
D. Kent (2008)
STATISTICAL AND GRAPHICAL EVIDENCE SYNTHESIS METHODS IN HEALTH TECHNOLOGY ASSESSMENT
S. Tan (2016)
Quantifying nonsteroidal anti-inflammatory drug (NSAID) risk: can combining the evidence with the use of a network meta-analysis provide a solution?
R. Woodman (2011)
A word from our moderator.
I. Shrier (2007)
Differential Effects of D-Hormone Analogs and Native Vitamin D on the Risk of Falls: A Comparative Meta-Analysis
F. Richy (2008)
Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.
N. Cooper (2009)
Benefit assessment in Germany : requirements & challenges presented for 6 topics German Translation : Nutzenbewertung in Deutschland : Anforderungen und Herausforderungen beispielhaft für 6 Themen
Johanna Gillhaus (2017)See more